
As Senate Panel Eyes Chronic Illness, NACDS Positions Pharmacy as Solution
PRESS RELEASE
July 15, 2014, Arlington, Va. — The National Association of Chain Drug Stores (NACDS) today put forward pharmacy-specific solutions as the Senate Finance Committee conducted a hearing on “Chronic Illness: Addressing Patients’ Unmet Needs.”
In a
“We are pleased that the legislation specifically recognizes the contributions provided by pharmacists to improve care to patients with chronic conditions,” NACDS wrote.
“Through personal interactions with patients, face-to-face consultations, and convenient access to preventive care services, local pharmacists are helping to shape the healthcare delivery system of tomorrow—in partnership with doctors, nurses, and others.”
NACDS emphasized the education and training of pharmacists, saying, “Specifically, community pharmacists are trained and educated to provide comprehensive chronic medication management, health screenings, preventative care, and pharmacogenomics counseling; order and interpret lab tests; initiate and modify medication regimens; provide rapid diagnostic testing (e.g. flu, strep and others); perform physical assessments; and provide immunizations and health and wellness care.”
The statement also noted the importance of enhancing the eligibility for medication therapy management services, and of formally recognizing pharmacists as healthcare providers in selected government programs.
NACDS supports the “
“Since community pharmacists have the proven ability to provide services that lead to better clinical outcomes and lower healthcare costs, allowing them to practice up to their full extent will prove beneficial for all patients, including those suffering from chronic illnesses. Increasing access to community pharmacists will improve health and reduce overall healthcare spending by reduced complications that lead to increased use of expensive medical services and hospitalizations,” wrote NACDS in summarizing its statement to the Senate Finance Committee.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.